stockrowInspire Medical Systems, Inc.
INSP Healthcare Medical Devices
Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.
- Revenue
- −7.93%
- EPS
- −348.0%
- Free cash flow
- −33.1%
Quarter to September 2026, against a year earlier
Follow INSP
Alert me
Inspire Medical Systems, Inc. (INSP) P/E ratio
As of 5 November 2026, Inspire Medical Systems, Inc. (INSP) trades at a P/E ratio of 19.1×. Over the past ten years it has ranged from 0.0× (June 2024) to 1,084× (September 2024); the current reading is higher than 81% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 18.4× | (82.26%) |
| FY2024 | 104× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 19.9× | 108.39% |
| Jun 2026 | 9.6× | (15.93%) |
| Mar 2026 | 11.4× | (38.03%) |
| Dec 2025 | 18.4× | (62.86%) |
| 35 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| ENOV Enovis Corporation compare | n/m |
| ALMR Alamar Biosciences, Inc. compare | n/m |
| TMDX TransMedics Group, Inc. compare | 16.4× |
| INSP Inspire Medical Systems, Inc. | 19.1× |
| CNMD CONMED Corporation compare | 21.7× |
| UFPT UFP Technologies, Inc. compare | 30.1× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)